← Leaderboards
Claire Clelland
University Of California, San Francisco
$2,800,410
Attributed
$3,235,389
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,235,389 · 3
By mechanism
U19$1,190,930 · 1
K08$1,174,500 · 1
U01$869,959 · 1
Top collaborators
- Shaoqin - Gong1 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Deepak Ashok Lamba$4,257,564
- Kathleen R Chirco$1,017,200
- Michael T McManus$36,428,993
- Joshua Frederick Robinson$4,273,620
- Gregory Michael Ku$5,449,009
Others in their field
Other Emerging Leaders on “Curative Treatments”
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,420,423
- Greg Yothers · University Of Chicago$35,003,821
- Olwen Hahn · Brigham And Women'S Hospital$13,427,021
- Rene S. Kahn · Icahn School Of Medicine At Mount Sinai$13,240,338
- Barbara Burtness · Yale University$11,604,189
- Angelo A. Cardoso · Beckman Research Institute/City Of Hope$10,820,438
Research focus
Curative TreatmentsC9orf72NeuronsGenesCrispr/Cas TechnologyClustered Regularly Interspaced Short Palindromic RepeatsClinically RelevantNeurodegenerative DisordersGeneticEffective TherapyMutationCellsMutantPathologicAllelesTechnologyCrispr TherapeuticsBrainGuide RnaNovel Therapeutic InterventionPathogenicityDesignMotor NeuronsLink
Grant awards (9)
Research Project II: AAV-CRISPR to Treat Amyotrophic Lateral Sclerosis$623,889
U19 · FY2025 · NS · contact PI
Research Project II: AAV-CRISPR to Treat Amyotrophic Lateral Sclerosis$567,041
U19 · FY2024 · NS · contact PI
CRISPR-Cas9 editing in C9orf72 patient derived iPSC$240,300
K08 · FY2024 · NS · contact PI
Optimization of CRISPR genome editor and its delivery strategy for C9orf72 frontotemporal dementia$869,959
U01 · FY2023 · NS · contact PI
CRISPR-Cas9 editing in C9orf72 patient derived iPSC$240,300
K08 · FY2023 · NS · contact PI
CRISPR-Cas9 editing in C9orf72 patient derived iPSC$213,300
K08 · FY2022 · NS · contact PI
CRISPR-Cas9 editing in C9orf72 patient derived iPSC$213,300
K08 · FY2021 · NS · contact PI
CRISPR-Cas9 editing in C9orf72 patient derived iPSC$54,000
K08 · FY2021 · NS · contact PI
CRISPR-Cas9 editing in C9orf72 patient derived iPSC$213,300
K08 · FY2020 · NS · contact PI